Format

Send to:

Choose Destination
See comment in PubMed Commons below
World J Gastroenterol. 2013 Jun 14;19(22):3459-65. doi: 10.3748/wjg.v19.i22.3459.

Perceptions about preventing hepatocellular carcinoma among patients with chronic hepatitis in Taiwan.

Author information

  • 1Department of Nursing, I-Shou University, Kaohsiung 82445, Taiwan.

Abstract

AIM:

To measure patient perceptions about preventing hepatocellular carcinoma (HCC) and to predict the factors that influence patient willingness to receive therapy.

METHODS:

A cross-sectional descriptive study was conducted at an outpatient clinic of a medical institution in southern Taiwan. Four hundred patients with chronic hepatitis B/C were recruited as participants. Two structured questionnaires based on the health belief model were utilized in this study, including the scales of perceptions about preventing HCC and knowledge of hepatitis B/C.

RESULTS:

The statistical results demonstrated that the participants' perceived susceptibility (r = -0.22, P < 0.001), benefits (r = -0.11, P = 0.028) and cues to action (r = -0.12, P = 0.014) about the prevention of HCC was significantly correlated with their age. The participants' perceptions were also associated with their educational levels, household incomes and knowledge of hepatitis. Older patients and those with a lower socioeconomic status tended to have negative perceptions and less knowledge of hepatitis. Multivariate logistic regression further indicated that the participants' age (B = -0.044, SE = 0.017, odds ratio = 0.957, P = 0.008, 95%CI: 0.926-0.989) and perceived barriers (B = -0.111, SE = 0.030, odds ratio = 0.895, P < 0.001, 95%CI: 0.845-0.949) were correlated with their willingness to receive antiviral therapy.

CONCLUSION:

Healthcare professionals should provide appropriate and effective guidance to increase their patients' awareness and to decrease the perceived barriers for continuing surveillance and antiviral therapy.

KEYWORDS:

Antiviral therapy; Health knowledge; Health perception; Hepatitis B; Hepatitis C; Hepatocellular carcinoma

PMID:
23801839
[PubMed - indexed for MEDLINE]
PMCID:
PMC3683685
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Baishideng Publishing Group Inc. Icon for PubMed Central
    Loading ...
    Write to the Help Desk